IPWatchdog14h
Pharma Companies’ Challenge to Inflation Reduction Act Heats Up
Patients for Affordable Drugs (“P4AD”) became the latest amicus to file a brief with the U.S. Court of Appeals for the Third ...
IPWatchdog19h
Chamber’s GIPC Tells USPTO to Pivot on Coordination Plans with FDA
The U.S. Chamber of Commerce’s Global Innovation Policy Center (GIPC) published a blog post Friday urging the U.S. Patent and ...
IPWatchdog14h
CAFC Says District Court Erred in Claim Construction Analysis that Held Teleflex Patents Invalid
“The district court’s finding that the claims were mutually exclusive ‘forced itself into a later conclusion of ...
IPWatchdog12h
Comment Period for USPTO’s AI Eligibility Guidance Extended by One Month
The U.S. Patent and Trademark Office (USPTO) today announced that it will extend the comment period for its “2024 Guidance ...